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Abstract
Background: Growth hormone (GH) has many direct and indirect actions and roles including substrate regulation
and priming of some cells of the immune system, and the expected aspects of growth and repair. Different
concentrations in human body fluids reflect the exercise-induced growth hormone response (EIGR) after exercise. In
populations such as elite athletes, the invasive nature of venous sampling is poorly accepted. Thus, this study
examines possible viable alternatives such as urine and saliva samples and the GH concentration.
Methods: A heterogeneous group of 11 males (age 26.0 ± 5.0 years; body mass 76.5 ± 9.3 kg; VO2peak 57.0 ± 6.
0 mL kg−1 min−1) ran for 40 min on a treadmill at 5 % below their individually indentified lactate threshold pace.
Samples of urine, saliva and blood were collected immediately pre- and post-test and at 30 and 60 min post-test.
Results: Salivary GH was correlated with serum pre- and post-exercise (p < 0.001); urinary GH was correlated with
serum (p < 0.05). However, despite being significantly correlated, it is clear from the large differences in absolute
concentration in the three media that the appearance of serum GH due to exercise is different from that of the
appearance of salivary and urinary GH. This aspect of compartmental exchanges is very difficult to define and to
investigate. Differences in any analyte concentration in different compartments are to be expected between
different media, and hence the same medium should be used where the same ‘pattern of response’ can be
tracked.
Conclusions: The results suggest that urinary and saliva sampling cannot substitute for venous sampling with
respect to exercise-induced changes in GH concentration. The use of the analyses in these three areas may be
appropriate for further investigation.
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Key Points
1. Traditionally, analysis of the exercise-induced
growth hormone (GH) response in athletes has
required venous blood sampling.
2. Elite athlete involvement in research is often
dependent on less invasive methods of assessment
and so the current study has investigated
alternatives to venous sampling in athletes.
3. The findings from this study suggest that it may be
possible to use blood, saliva and urine
interchangeably, in assessing GH secretion in
exercise, but confirmation of this will require further
investigation.
Background
For many decades, growth hormone (GH) was believed to
have little or no physiological consequence beyond pu-
berty. Today, it is known that growth hormone has a host
of functions including growth, repair, substrate regulation
[1], maintenance of a healthy body composition, mainten-
ance of exercise capacity and a role in immune function
[2]. GH has a considerable effect on the liver, the site of
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insulin-like growth factor (IGF-1) secretion which is the
main hormone linked to GH secretion.
Growth hormone is released in response to physical
exercise. The highest transient GH concentrations result
from high-intensity exercise (that sustained for 30 s);
sustained rises in GH occur where exercise is at an in-
tensity equivalent to lactate threshold or above and is
sustained for more than 10 min [3–6]. Exercise also has
the ability to override the normal pulsatile secretion of
GH [7]. Many of its exercise-induced roles are as yet un-
known but recent evidence suggests it may result in
post-exercise lipolysis [8]. There has been speculation
that growth hormone may potentiate adaptation result-
ing from exercise and hence this, along with its role in
substrate manipulation and in immune function, makes
the exercise-induced GH response (EIGR) a target of
interest for further research.
The traditional method of venous sampling in individ-
uals, being more invasive, often leads to a reduced num-
ber of willing participants. Thus, the viability of less
invasive alternatives such as urine and saliva sampling is
tested here on athletes. GH concentrations in different
media such as saliva and urine in comparison with that
in the general circulation after exercise have not been
previously investigated.
The aim of this study was to examine changes of GH
in saliva, urine and serum after moderate-intensity exer-
cise of moderate duration and to assess the validity of
different sample media (saliva and urine) in comparison
with analyte measurement in the blood.
Methods
Participants
Healthy male subjects (N = 11) were recruited from local
running clubs and university students and provided
signed informed consent. The participants were aged 26
± 5 years, with those under 18 or over 35 years being ex-
cluded, and their characteristics are provided in Table 1.
Ethical approval was granted by the Ethics Committee of
the School of Sport and Education, Brunel University,
and the tenets of the Helsinki Declaration were observed
throughout.
Protocol
Participants undertook an incremental exercise test on
the treadmill to determine lactate threshold and VO2peak.
After a 5-min warm-up (10 kph), a suitable starting
speed was chosen and participants ran at this speed for
4 min then straddled the treadmill for 30 s, while an ear-
lobe capillary blood sample was obtained. The speed of
the treadmill was then increased by 0.5 km h−1, and par-
ticipants ran at this speed for 4 min. This process was
repeated for a total of five to eight stages, the test proto-
col taking between 22 and 35.5 min. The criteria for the
last stage was a respiratory exchange ratio (RER) consist-
ently at, or above, 1.00. Heart rate (HR) was recorded
during the last 30 s of each stage using a Polar heart rate
monitor (Polar S610i, Polar Electro Oy, Finland). At the
end of the last 4-min stage, a final capillary blood sample
was taken as before. Participants then completed 1 min
at the same speed and gradient. Thereafter, the gradient
of the treadmill was increased by 1 % every minute until
(1) volitional exhaustion, (2) a plateau in VO2 or (3) an
RER greater than 1.15 and HR within five beats min−1 of
age-predicted maximum [9]. VO2peak was taken as the
highest average value for VO2 over a 30-s period. Oxy-
gen consumption (VO2) and carbon dioxide production
(VCO2) during exercise were assessed using an online
gas analyser (Oxycon Pro, Jaeger, Germany). Prior to
every trial, the gas analysers were calibrated using
known concentrations of CO2 and O2 (Air Products Ltd,
London) and the flow-volume sensor was calibrated
using a 3-litre syringe; giving rise to a CV of <2.0 %.
Within 5–8 days after this test, participants returned
to the laboratory to complete a 40-min run at 5 % below
the speed at lactate threshold (main trial). In an attempt
to standardise the condition of each participant, they
were asked to maintain a similar dietary regimen before
each trial. In addition, a 3-day food diary was completed
and was analysed for percentage of energy derived from
carbohydrate, fat and protein using Dietplan6 (Forest-
field Software Ltd, UK).
Participants were instructed to fast from 22:00 the
night before the test but were allowed to consume water
ad libitum. They reported to the laboratory between
07:30 and 08:00; a mid-stream urine sample was col-
lected, height and body mass were recorded and a HR
monitor was fitted. Participants rested in a seated pos-
ition for 10 min before an unstimulated, timed saliva
sample and then an 8-mL venous blood sample was col-
lected into a Vacutainer (Becton Dickinson). The sample
taken before the exercise was designated ‘Pre-Ex’.
A 5-min warm-up at a self-selected speed (average
10 kph), which was slower than the speed for the main
trial, was completed before the 40-min run at 5 % below
lactate threshold. Water (200 mL) was consumed during
the warm-up period and again during the first 10 min of
Table 1 Participant characteristics
Mean ± SD
Age (years) 26.0 ± 5.0
Height (cm) 179.0 ± 7.0
Body mass (kg) 76.5 ± 9.3
VO2peak (mL kg
−1 min−1) 57.0 ± 6.0
LT (% VO2peak) 79.0 ± 6.0
LT lactate threshold; N = 11
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exercise. As mentioned in the ‘Background’ section, sus-
tained rises in GH occur where exercise is at an intensity
equivalent to lactate threshold or above and the per-
formance is sustained for more than 10 min [4–6]. Ac-
cordingly, moderate exercise was investigated because it
fits with lactate threshold. (That is to say a sustained rise
in GH, rather than a transitory peak, requires exercise
for at least 10 min above threshold pace). Forty minutes
was selected because this corresponds to a good 10-km
time and a 10-km pace is generally associated with lac-
tate threshold. The key was a standardised time at just
below threshold and, since it was just below threshold,
the time was extended to ensure greater chances of
achieving steady state which can be more difficult to
achieve at, or approaching, threshold pace.
A respiratory gas facemask was worn throughout
the trial and respiratory gases were analysed in the
last 2 min of every 10 min to monitor exercise inten-
sity; HR was recorded every 10 min. On completion
of the main trial, participants returned to a seated
position; saliva, venous blood and urine were col-
lected in that order, within <15 min from the start of
saliva collection, at (Post-Ex) and after 30 min of rest
(Post-Ex 30); saliva and blood were also collected
after 60 min of rest (Post-Ex 60). Participants con-
sumed 200 mL of water after the collection of each
saliva sample. All samples were centrifuged, aliquotted
and stored within 2 h of the tests being completed.
Saliva Sampling
Participants were instructed not to have brushed their
teeth or drunk anything 30 min prior to each sample.
Participants rinsed out their mouths with water and
unstimulated, timed (over five min), saliva samples
were collected into pre-weighed plastic tubes via
drooling, to avoid a contribution from the parotid
gland [10, 11], and were immediately frozen at ≤−20 °
C. Subsequently, samples were thawed to break down
mucopolysaccharides that can interfere with pipetting
[12]. The samples were weighed and centrifuged at
1000g for 15 min at 20 °C and the clear part of the
saliva was aliquotted to multiple Eppendorf tubes and
frozen at ≤−20 °C until assay. Freeze-thaw cycles were
kept to a minimum. Immediately prior to assay, the
saliva was centrifuged again at 1000g for 10 min at
20 °C to remove any remaining particulate matter.
For the estimation of saliva flow rate (salivafr), it was
assumed that saliva density was 1 g mL−1 as sug-
gested by Walsh et al. [13]. Salivafr was calculated by
dividing the sample volume (mL) by the time (min)
taken to produce it. GH secretion rate (pg min−1)
was calculated by multiplying the absolute GH con-
centration (pg mL−1) by salivafr (mL min
−1) [14].
Blood Sampling
Venous blood was collected via venepuncture of an ante-
cubital vein into a vacutainer tube (Becton, Dickinson).
Serum (no anti-coagulant) was allowed to clot at room
temperature for at least 30 min before being centrifuged
at 1000g for 12 min at 20 °C. Serum was aliquoted into
multiple Eppendorf tubes and frozen at ≤−20 °C until
assay. Serum GH is remarkably stable, remaining so for
24 h at room temperature [15, 16]. Earlobe capillary
samples were collected into 1.7 mL haemolysing solution
and left at room temperature until assayed enzymatically
for lactate (Biosen C-lineSport, EZF Diagnostics,
Germany).
Urine Collection
As described, participants were well hydrated through-
out the study to ensure urine production. Urine was col-
lected mid-stream into plastic cups before being
transferred into centrifuge tubes, spun at 1000g for
12 min at 12 °C to remove particulate, then aliquoted to
multiple Eppendorf tubes and stored at ≤−20 °C until
assay, which was undertaken within 6 weeks.
Sample Analysis
For all assays, samples from the same participant
were analysed in the same assay and measured in
duplicate.
Serum GH was analysed via ELISA (Diagnostic Systems
Laboratories, Texas) in accordance with the manufac-
turers’ instructions. Optical density was measured using a
Titertek MS2 microplate reader. Assay sensitivity was
0.3 ng mL−1; intra- and inter-assay CVs were <5 and <7 %,
respectively.
Salivary and urinary GH concentration was measured
using the same high-sensitivity ELISA kits (Diagnostic
Systems Laboratories). For the salivary GH assay, stan-
dards and controls were diluted using mock saliva (4.2 g
NaOH, 0.5 g NaCl and 0.2 g KOH in 100 mL distilled
H2O. This mixture was diluted 1:10 in distilled water
prior to use. The assays were carried out according to
the manufacturer’s instructions. Optical density was de-
termined using a Titertek MS2 microplate reader. Assay
sensitivity was 0.66 pg mL−1, intra- and inter-assay CV
was <10.5 %.
Salivary GH concentrations were corrected for salivafr
as described above. Urinary GH concentrations were
corrected for creatinine (Crt) excretion to account for
diuresis. Urinary Crt was measured using a colorimetric
activity assay (R&D Systems, UK). A standard curve was
included with each assay. Urinary GH was calculated as
pg mol−1 Crt and the intra- and inter-assay CV were
≤3.5 and ≤5.5 %, respectively.
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Data Analysis
Normality was tested by examining normal plots of re-
siduals in ANOVA models. Residuals were regarded as
normally distributed if Kolmogorov-Smirnov tests were
not significant [17]. Data were log10 transformed to bet-
ter approach normality. One-way repeated measures
ANOVA was used to indicate significant changes over
time; when the assumption of sphericity was violated,
the p value was adjusted using the Greenhouse-Geisser
correction [17]. Where appropriate, paired-sample t tests
using the Bonferroni adjustment were used to indicate
changes compared to Pre-Ex. Associations between the
concentration of GH in saliva and urine with those in
serum were assessed by calculating Pearson’s (r) or
Spearman’s rho (rs) correlation coefficient depending on
whether the variables were normally distributed or not.
Data were analysed using SPSS for windows, version
13.0 (SPSS Inc., Chicago, USA).
Results
During the 40-min exercise bout, mean ± SD HR was
163 ± 9 beats min−1, VO2 was 44 ± 5 mL kg
−1 min−1 and
% VO2peak was 77 ± 5 %. The average daily energy de-
rived from carbohydrate, fat and protein (mean ± SD)
was 57 ± 9 %, 29 ± 8 % and 14 ± 2 %, respectively. A
complete data set for urine samples could not be ob-
tained at Post-Ex 60, and thus, these measurements were
confined to Post-Ex 30. Crt was not detected in one Pre
sample.
Changes in serum, salivary and urinary GH in re-
sponse to the exercise are presented in Table 2. Serum
GH changed significantly over time (F = 26.27, p <
0.001); at Post-Ex, serum GH was increased by 4.5-fold.
Absolute salivary concentration of GH (pg mL−1) chan-
ged significantly over time (F = 33.99, p < 0.001); it was
increased by 33-fold at Post-Ex, 40.5-fold at Post-Ex 30
and 35-fold at Post-Ex 60 compared with Pre-Ex. Similar
results were observed when salivary concentrations were
corrected for salivafr (pg min
−1). Increases of 58.5-fold,
72-fold and 50-fold were observed at Post-Ex Post-Ex 30
and Post-Ex 60, respectively, compared with Pre-Ex. The
concentration of urinary GH, both absolute and cor-
rected for Crt excretion, changed significantly over time
(F = 12.27, p < 0.001 and F = 7.12, p < 0.01, respectively).
The absolute concentration of urinary GH was increased
by 15.5-fold at Post-Ex and 25-fold at Post-Ex 30 com-
pared with Pre-Ex. The concentration of urinary GH
relative to Crt excretion was increased by 23-fold at
Post-Ex and 52-fold at Post-Ex 30 compared with Pre-
Ex. Despite rather weak correlations, serum GH was
significantly correlated with salivary GH before and after
exercise for both the absolute concentration and cor-
rected for salivafr (rs = 0.412, p < 0.01 and rs = 0.392, p <
0.01, respectively). Serum GH was significantly corre-
lated with the absolute concentration of urinary GH and
urinary GH corrected for Crt excretion (rs = 0.434, p <
0.05 and rs = 0.484, p < 0.01, respectively).
Discussion
The present study is the first to investigate the effect of
an acute bout of exercise on the concentration of GH
simultaneously in serum, urine and saliva. Dietary ana-
lysis (individual data not shown) revealed that partici-
pants derived a similar percentage of average daily
energy intake from carbohydrate, fat and protein. Thus,
the contribution of differences in dietary composition
can be considered to be minimal.
A significant correlation between serum and salivary
GH before and after the bout of exercise was observed
in the present study on males. Rantonen et al. also re-
ported a relationship between serum and salivary GH at
rest, but only in women [18]. The report of a significant
correlation between serum and urinary GH before and
after exercise is a novel finding.
Despite being significantly correlated, it is clear from
the results (Table 2) that the serum GH response to ex-
ercise is different from that of the salivary and urinary
GH responses. First, serum GH is in the nanogram
range, whereas urine and saliva GH is in the picogram
range. A lower concentration of GH in saliva compared
to serum has been observed [19]. It is also known that,
in the absence of disease, approximately 0.01 % of se-
creted GH is excreted into the urine, which would ex-
plain the low urinary concentrations [20].
Secondly, serum GH peaked at the end of the exercise
and returned to baseline by 30 min post-exercise. Salivary
Table 2 Serum, salivary and urinary GH in response to moderate-intensity exercise
Pre-Ex Post-Ex Post-Ex 30 Post-Ex 60
Serum (ng mL−1) 1.8 ± 1.2 8.2 ± 1.0*** 2.1 ± 0.5 0.7 ± 0.2
Saliva (pg mL−1) 0.6 ± 0.5 19.7 ± 6.0*** 24.3 ± 5.8*** 20.9 ± 8.3***
Salivafr (pg min
−1) 0.2 ± 0.2 11.7 ± 3.8*** 14.4 ± 4.8*** 10.0 ± 4.2***
Urine (pg mL−1) 5.1 ± 1.9 79.2 ± 32.3** 128.0 ± 83.0*
Urine (pg mol−1 Crt) 0.4 ± 0.2 9.3 ± 4.8** 20.9 ± 16.3*
Data are mean ± SEM (N = 11), significantly different from Pre-Ex
Salivafr saliva flow rate, Crt creatinine
*p < 0.05; **p < 0.01; ***p < 0.001
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GH increased immediately after exercise, peaked at
30 min post-exercise and remained above baseline until
1 h post-exercise. Urinary GH was also increased immedi-
ately after exercise and was increased further at 30 min
post-exercise. Hence, the pattern of change in systemic
GH was not reflected in saliva or urine in the present
study. The metabolic clearance rate of GH might be a fac-
tor. In healthy humans, the clearance of recombinant hu-
man (rh) GH appears to be inversely related to plasma
GH concentration [21]. Therefore, it is possible that, in
the present study, when serum GH was high immediately
post-exercise, clearance via processes in the kidney and
saliva may have been low. As serum GH decreased in the
hour after exercise, metabolic clearance rate may have in-
creased leading to the increased appearance of GH in sal-
iva and urine. Another possible explanation concerning
urinary excretion of GH is the linear relationship between
metabolic clearance rate and glomerular filtration rate ob-
served by Haffner et al. [21]. It is tempting to speculate
that, if the metabolic clearance rate of GH increased in
the hour after exercise, the filtration rate of GH would
lead to an increase in the appearance of GH in urine.
Findings from this study suggest that salivary and
urinary GH concentrations are not viable alternatives to
serum measures of GH concentration as an index of sys-
temic GH concentration. It would have been interesting
to compare different intensities/duration of exercise, to
see if any correlations (comparison of different sample
media compared to blood measurement) occurred.
Conclusions
This is the first study to measure simultaneous changes
in salivary, urinary and systemic concentration of GH,
before and after an acute bout of exercise. Serum, saliv-
ary and urinary GH were significantly increased immedi-
ately after exercise, but did not have a similar pattern of
change over time. GH concentrations were markedly
higher in serum than in saliva and urine. The appear-
ance of GH in saliva and urine after exercise may be re-
lated to its clearance from the circulation. There appears
to be a paucity of research examining the mechanisms
behind the entry of GH into saliva and urine after
exercise.
Further research, perhaps using radio labelling with
I125, would greatly enhance our understanding of GH
clearance during exercise, but understanding clearance
after exercise may prove more problematic.
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